The company is scaling up manufacturing and commercial activities as it prepares to enter the U.S. market via the Food and Drug Administration’s de novo pathway.

Haag, who has worked at Medtronic for 20 years, will also serve on the leadership team for the neuroscience group.

The research initiative is part of a broader focus on wearables at the Department of Health and Human Services.

MiniMed, Medtronic’s diabetes tech spinoff, made its debut on the public markets Friday. The company started trading on the ...

Intuitive co-founder Fred Moll invested $2 million, supporting SS Innovations’ efforts to launch its robot in the U.S.

Expecting pivotal data this year, the company has raised a Series C round to support the launch of a noninvasive device ...

The robotics company, which has taken steps to preserve cash amid the latest change of course in the development of its ...

Biocare’s strong growth in immunohistochemistry is expected to strengthen Agilent’s ability to develop new in vitro diagnostic antibodies.

UFP Technologies, a Massachusetts-based medical device maker, said it is investigating a cyberattack in mid-February that led to some of its company data being stolen or potentially destroyed, ...

CEO Massimiliano Colella delayed introducing the company’s soft tissue surgery system in the U.S. by a year but says the improved robot that is hitting the market now was worth the wait.

Buying Gleamer will expand the capabilities RadNet acquired through the DeepHealth buyout in 2020, particularly in X-ray, and ...

Fresenius has issued a software release to address issues that could interrupt treatment with its Ivenix large volume pumps.